DRUG-THERAPY - ERYTHROPOIETIN

被引:379
作者
ERSLEV, AJ
机构
[1] Cardeza Foundation for Hematologic Research, Department of Medicine, Jefferson Medical College, Philadelphia, PA 19107
关键词
D O I
10.1056/NEJM199105093241907
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
THE red-cell mass is continuously adjusted to the optimal size for its function as an oxygen carrier by messages transmitted to the bone marrow from an oxygen sensor in the kidney. These messages are mediated by the hormone erythropoietin, are modulated by cardiovascular and renal factors, and form a key link in the feedback loop that controls the production of red cells (Fig. 1).1 Erythropoietin is a glycoprotein growth factor synthesized by cells adjacent to the proximal renal tubules in response to signals from a renal oxygen-sensing device, probably a heme protein.2 In the bone marrow, erythropoietin binds to and. © 1991, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:1339 / 1344
页数:6
相关论文
共 54 条
[1]   BODY-FLUID SPACES AND BLOOD-PRESSURE IN HEMODIALYSIS-PATIENTS DURING AMELIORATION OF ANEMIA WITH ERYTHROPOIETIN [J].
ABRAHAM, PA ;
OPSAHL, JA ;
KESHAVIAH, PR ;
COLLINS, AJ ;
WHALEN, JJ ;
ASINGER, RW ;
MCLAIN, LA ;
HANSON, G ;
DAVIS, MG ;
HALSTENSON, CE .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1990, 16 (05) :438-446
[2]   ERYTHROPOIETIN FOR THE TREATMENT OF PORPHYRIA CUTANEA-TARDA IN A PATIENT ON LONG-TERM HEMODIALYSIS [J].
ANDERSON, KE ;
GOEGER, DE ;
CARSON, RW ;
LEE, SMK ;
STEAD, RB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (05) :315-317
[3]   BLUNTED ERYTHROPOIETIN RESPONSE TO ANEMIA IN RHEUMATOID-ARTHRITIS [J].
BAER, AN ;
DESSYPRIS, EN ;
GOLDWASSER, E ;
KRANTZ, SB .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 66 (04) :559-564
[4]  
Besarab A, 1990, ASAIO Trans, V36, pM749
[5]  
BESARAB A, IN PRESS J AM SOC NE
[6]   MARKED ERYTHROPOIETIN INCREASE BEFORE FALL IN HB AFTER TREATMENT WITH CYTOSTATIC DRUGS SUGGESTS MECHANISM OTHER THAN ANEMIA FOR STIMULATION [J].
BIRGEGARD, G ;
WIDE, L ;
SIMONSSON, B .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (03) :462-466
[7]  
BLUMBERG N, 1989, ARCH PATHOL LAB MED, V113, P246
[8]   THE TREATMENT OF ANEMIA IN THE MYELODYSPLASTIC SYNDROMES WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN [J].
BOWEN, D ;
CULLIGAN, D ;
JACOBS, A .
BRITISH JOURNAL OF HAEMATOLOGY, 1991, 77 (03) :419-423
[9]   DECREASED RESPONSE OF PLASMA-IMMUNOREACTIVE ERYTHROPOIETIN TO AVAILABLE OXYGEN IN ANEMIA OF PREMATURITY [J].
BROWN, MS ;
GARCIA, JF ;
PHIBBS, RH ;
DALLMAN, PR .
JOURNAL OF PEDIATRICS, 1984, 105 (05) :793-798
[10]  
COHEN RA, 1985, P SOC EXP BIOL MED, V179, P296